TIVA vs TXA in Sinus Surgery to Evaluate Operative Blood Loss and Surgical Field Quality

Last updated: March 21, 2023
Sponsor: Our Lady of the Lake Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Head And Neck Cancer

Treatment

N/A

Clinical Study ID

NCT05639686
TIVA vs TXA in Sinus Surgery
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this interventional study is to compare the efficacy (surgical field quality and intra-operative blood loss) or cost of TIVA alone to general inhalational anesthetics with intravenous TXA in patient participants who are undergoing endoscopic sinus surgery.

The main questions the study aims to answer are:

  • Is the surgical field quality better when using TIVA alone compared to general inhalational anesthetics with intravenous TXA?

  • Is one method more financially advantageous to the participant and the institution compared to the other method?

Participants will be randomized into one of the two anesthesia cohorts prior to sinus surgery. One group will be given total intravenous anesthesia (TIVA) alone and the other will be given intravenous tranexamic acid (TXA) followed by general inhalational anesthesia.

Researchers will compare the TIVA group to the TXA group to see if one group exhibits a better surgery field viewing quality through a subjective evaluation and measurement of blood loss and also which anesthesia regimen is most cost effective upon conducting a cost analysis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • adults (age ≥18 years)
  • will undergo endoscopic sinus surgery at Our Lady of the Lake Regional Medical Center
  • includes patients who are undergoing endoscopic sinus surgery for myriad ofindications, such as chronic rhinosinusitis, sinonasal tumors, and encephalocelerepairs.
  • includes patients who undergo both complete functional endoscopic sinus surgery, orFESS (i.e maxillary antrostomy, sphenoethmoidectomy, and frontal sinusotomy), as wellas those who are undergoing limited functional endoscopic sinus surgeries (i.e.anything less than a complete FESS).

Exclusion

Exclusion Criteria:

  • <18 years of age
  • history of bleeding or coagulation disorder
  • currently receiving anticoagulation therapy
  • underlying condition with increased risk of thrombosis (e.g. antiphospholipidsyndrome),
  • history of thromboembolic disorder
  • history of chronic kidney disease
  • known allergy to tranexamic acid

Study Design

Total Participants: 100
Study Start date:
January 01, 2023
Estimated Completion Date:
July 01, 2025

Study Description

This study aims to prospectively compare surgical field quality and intraoperative blood loss between patients treated with perioperative intravenous tranexamic acid (TXA) followed by general inhalational anesthesia (sevoflurane, isoflurane, or desflurane) to total intravenous anesthesia (TIVA) alone, which consists of propofol and remifentanil. A secondary objective would be to perform a cost analysis between these two groups to determine whether one method is financially more advantageous than the other.

This study will be a prospective double-blinded randomized control trial consisting of patients undergoing endoscopic sinus surgery to assess intraoperative blood loss, surgical field quality, and cost of the medications administered. The control group will receive total intravenous anesthesia without tranexamic acid during surgery. The study group will receive preoperative tranexamic acid with general inhaled anesthetics during surgery (detailed below). Randomization will be conducted via a pre-determined permuted block system (e.g. AABB, ABAB, BBAA, AABB, etc, where A is TIVA and B is general inhalational anesthetics with preoperative TXA). Subjects who consent to participate will be assigned to the A or B arm depending on whichever arm is listed next in the order.

Subjects will be informed about the study and consented during pre-operative clinic visits. The patient consent and HIPAA authorization forms will be presented at that time where the subject can read about the study followed by any verbal conversation or questions needed between the subject and the study team. This will be done in a private patient room setting. The subject will be notified that participation in the study is completely voluntary and that their medical care will not be affected regardless of their decision to participate. Of note, if patients decline to participate, they will undergo general anesthesia using TIVA without TXA, as this is the standard choice at our institution. Subjects will not receive payment or compensation for their participation.

Connect with a study center

  • Our Lady of the Lake Hospital

    Baton Rouge, Louisiana 70808
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.